Company Filing History:
Years Active: 2008-2014
Title: The Innovations of Bernard W Beall
Introduction
Bernard W Beall is a notable inventor based in Doraville, GA (US). He has made significant contributions to the field of immunology, particularly in the development of peptide vaccines. With a total of 4 patents, his work has the potential to impact public health positively.
Latest Patents
One of his latest patents focuses on peptide vaccines against group A streptococci. This invention relates to synthetic immunoreactive peptides that are approximately 20-25 amino acids in length. These peptides are derived from the N termini of the M proteins of the most prevalent Group A (GAS) serotypes in the United States. Some of these synthetic peptides can be recognized by M type-specific antibodies and are capable of eliciting functional opsonic antibodies and/or anti-attachment antibodies without causing tissue cross-reactive antibodies. The invention also encompasses compositions or vaccines that include these synthetic serotype-specific peptides, as well as isolated antibodies raised in response to the peptides, compositions, or vaccines. Furthermore, it relates to kits for utilizing the peptides, compositions, or antibodies, along with methods for using them and tailoring vaccines.
Career Highlights
Bernard W Beall is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on groundbreaking research in vaccine development.
Collaborations
He has collaborated with notable colleagues such as George M Carlone and Jacquelyn S Sampson, contributing to the advancement of immunological research.
Conclusion
Bernard W Beall's innovative work in peptide vaccines showcases his dedication to improving health outcomes through scientific research. His contributions are vital in the ongoing fight against infectious diseases.